Global Dry Skin Treatment Market

Dry Skin Treatment Comprehensive Study by Type (Moisturizer (Humectants, Emollients), Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others)), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Medication (OTC Products, Prescription Medications), End User (Hospitals, Homecare, Others) Players and Region - Global Market Outlook to 2030

Dry Skin Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dry Skin Treatment
The global dry skin treatment market is expected to grow in the future due to a rise in aesthetic concern and untapped emerging economies. Dry skin is also known as xeroderma is a condition of skin that occurs when skin cells produce less sebum (natural oils) than necessary. This lack of sebum results in flakes in the skin, chaps, feels tight and looks dull, especially on the cheeks and arounds the eyes. Dryness is exacerbated by wind, extremes of temperature and air conditioning. It usually not serious, but it can be uncomfortable and creating fine lines and wrinkles.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Dry Skin Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

L'Oreal SA (France), Galderma Laboratories (United States), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Bayer AG (Germany), Pfizer Inc (United States), MC2 Therapeutics (Denmark), Croda International Plc (United Kingdom), Unilever (United Kingdom), Johnson & Johnson Services, Inc (United States) and Perrigo Company plc (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Dry Skin Treatment market by Type (Moisturizer (Humectants, Emollients) and Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others)) and Region.



On the basis of geography, the market of Dry Skin Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Dry Skin Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacy will boost the Dry Skin Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Medication, the sub-segment i.e. OTC Products will boost the Dry Skin Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Dry Skin Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
High Prevalence of Dry Skin and Emergence of Grey Market and Free Trade Zone

Challenges:
Lack of Awareness about Dry Skin Treatment

Restraints:
Limited Operating Revenue Opportunities for Research and Development of Targeted Therapies by Many Pharmaceuticals and Low Healthcare Budget in Some Developing Countries

Opportunities:
The Rise in Continuously Investing Into Their R&D to Come Up With New Features or Products and Increasing Willingness of Spending More into Skincare Treatment

Market Leaders and their expansionary development strategies
In February 2022, Launching another product in the skincare category, drug major Cadila Pharmaceuticals has launched an intense moisturising formula to treat dry skin conditions. Christened Laglo Soft Lotion, the formula is used to treat dry skin conditions and associated disorders. It is proven to be effective in treating Xerosis, Ichthyosis, Atopic Dermatitis, Psoriasis, Skin Ageing, and Co-therapy with Corticosteroids.
In Sept 2019, MC2 Therapeutics filed New Drug Application (NDA) to the FDA Wynzora™ Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%) for the treatment of plaque psoriasis. In the press release company also mentioned that they intends to launch an innovative new line of PAD™ Cream-based consumer healthcare products for the treatment of dry, itchy and sensitive skin.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Dry Skin Treatment Provider, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Moisturizer (Humectants, Emollients)
  • Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others)
By Route of Administration
  • Oral
  • Topical

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Medication
  • OTC Products
  • Prescription Medications

By End User
  • Hospitals
  • Homecare
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Dry Skin
      • 3.2.2. Emergence of Grey Market and Free Trade Zone
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Dry Skin Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dry Skin Treatment, by Type, Route of Administration, Distribution Channel, Medication, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Dry Skin Treatment (Value)
      • 5.2.1. Global Dry Skin Treatment by: Type (Value)
        • 5.2.1.1. Moisturizer (Humectants, Emollients)
        • 5.2.1.2. Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others)
      • 5.2.2. Global Dry Skin Treatment by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Topical
      • 5.2.3. Global Dry Skin Treatment by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacy
        • 5.2.3.2. Retail Pharmacy
        • 5.2.3.3. Online Pharmacy
      • 5.2.4. Global Dry Skin Treatment by: Medication (Value)
        • 5.2.4.1. OTC Products
        • 5.2.4.2. Prescription Medications
      • 5.2.5. Global Dry Skin Treatment by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Homecare
        • 5.2.5.3. Others
      • 5.2.6. Global Dry Skin Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Dry Skin Treatment (Price)
      • 5.3.1. Global Dry Skin Treatment by: Type (Price)
  • 6. Dry Skin Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. L'Oreal SA (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Galderma Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sun Pharmaceutical Industries Ltd (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teva Pharmaceutical Industries Ltd (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MC2 Therapeutics (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Croda International Plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Unilever (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Johnson & Johnson Services, Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Perrigo Company plc (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Dry Skin Treatment Sale, by Type, Route of Administration, Distribution Channel, Medication, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Dry Skin Treatment (Value)
      • 7.2.1. Global Dry Skin Treatment by: Type (Value)
        • 7.2.1.1. Moisturizer (Humectants, Emollients)
        • 7.2.1.2. Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others)
      • 7.2.2. Global Dry Skin Treatment by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Topical
      • 7.2.3. Global Dry Skin Treatment by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacy
        • 7.2.3.2. Retail Pharmacy
        • 7.2.3.3. Online Pharmacy
      • 7.2.4. Global Dry Skin Treatment by: Medication (Value)
        • 7.2.4.1. OTC Products
        • 7.2.4.2. Prescription Medications
      • 7.2.5. Global Dry Skin Treatment by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Homecare
        • 7.2.5.3. Others
      • 7.2.6. Global Dry Skin Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Dry Skin Treatment (Price)
      • 7.3.1. Global Dry Skin Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dry Skin Treatment: by Type(USD Million)
  • Table 2. Dry Skin Treatment Moisturizer (Humectants, Emollients) , by Region USD Million (2018-2023)
  • Table 3. Dry Skin Treatment Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others) , by Region USD Million (2018-2023)
  • Table 4. Dry Skin Treatment: by Route of Administration(USD Million)
  • Table 5. Dry Skin Treatment Oral , by Region USD Million (2018-2023)
  • Table 6. Dry Skin Treatment Topical , by Region USD Million (2018-2023)
  • Table 7. Dry Skin Treatment: by Distribution Channel(USD Million)
  • Table 8. Dry Skin Treatment Hospital Pharmacy , by Region USD Million (2018-2023)
  • Table 9. Dry Skin Treatment Retail Pharmacy , by Region USD Million (2018-2023)
  • Table 10. Dry Skin Treatment Online Pharmacy , by Region USD Million (2018-2023)
  • Table 11. Dry Skin Treatment: by Medication(USD Million)
  • Table 12. Dry Skin Treatment OTC Products , by Region USD Million (2018-2023)
  • Table 13. Dry Skin Treatment Prescription Medications , by Region USD Million (2018-2023)
  • Table 14. Dry Skin Treatment: by End User(USD Million)
  • Table 15. Dry Skin Treatment Hospitals , by Region USD Million (2018-2023)
  • Table 16. Dry Skin Treatment Homecare , by Region USD Million (2018-2023)
  • Table 17. Dry Skin Treatment Others , by Region USD Million (2018-2023)
  • Table 18. South America Dry Skin Treatment, by Country USD Million (2018-2023)
  • Table 19. South America Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 20. South America Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 21. South America Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 22. South America Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 23. South America Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 24. Brazil Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 25. Brazil Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 26. Brazil Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 27. Brazil Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 28. Brazil Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 29. Argentina Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 30. Argentina Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 31. Argentina Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 32. Argentina Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 33. Argentina Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 34. Rest of South America Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 35. Rest of South America Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 36. Rest of South America Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 37. Rest of South America Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 38. Rest of South America Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 39. Asia Pacific Dry Skin Treatment, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 42. Asia Pacific Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 43. Asia Pacific Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 44. Asia Pacific Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 45. China Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 46. China Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 47. China Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 48. China Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 49. China Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 50. Japan Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 51. Japan Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 52. Japan Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 53. Japan Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 54. Japan Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 55. India Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 56. India Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 57. India Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 58. India Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 59. India Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 60. South Korea Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 61. South Korea Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 62. South Korea Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 63. South Korea Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 64. South Korea Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 65. Taiwan Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 66. Taiwan Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 67. Taiwan Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 68. Taiwan Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 69. Taiwan Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 70. Australia Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 71. Australia Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 72. Australia Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 73. Australia Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 74. Australia Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 77. Rest of Asia-Pacific Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 78. Rest of Asia-Pacific Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 79. Rest of Asia-Pacific Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 80. Europe Dry Skin Treatment, by Country USD Million (2018-2023)
  • Table 81. Europe Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 82. Europe Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 83. Europe Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 84. Europe Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 85. Europe Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 86. Germany Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 87. Germany Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 88. Germany Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 89. Germany Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 90. Germany Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 91. France Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 92. France Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 93. France Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 94. France Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 95. France Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 96. Italy Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 97. Italy Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 98. Italy Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 99. Italy Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 100. Italy Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 101. United Kingdom Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 102. United Kingdom Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 103. United Kingdom Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 104. United Kingdom Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 105. United Kingdom Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 106. Netherlands Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 107. Netherlands Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 108. Netherlands Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 109. Netherlands Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 110. Netherlands Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 111. Rest of Europe Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 112. Rest of Europe Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 113. Rest of Europe Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 114. Rest of Europe Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 115. Rest of Europe Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 116. MEA Dry Skin Treatment, by Country USD Million (2018-2023)
  • Table 117. MEA Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 118. MEA Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 119. MEA Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 120. MEA Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 121. MEA Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 122. Middle East Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 123. Middle East Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 124. Middle East Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 125. Middle East Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 126. Middle East Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 127. Africa Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 128. Africa Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 129. Africa Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 130. Africa Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 131. Africa Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 132. North America Dry Skin Treatment, by Country USD Million (2018-2023)
  • Table 133. North America Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 134. North America Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 135. North America Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 136. North America Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 137. North America Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 138. United States Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 139. United States Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 140. United States Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 141. United States Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 142. United States Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 143. Canada Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 144. Canada Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 145. Canada Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 146. Canada Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 147. Canada Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 148. Mexico Dry Skin Treatment, by Type USD Million (2018-2023)
  • Table 149. Mexico Dry Skin Treatment, by Route of Administration USD Million (2018-2023)
  • Table 150. Mexico Dry Skin Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 151. Mexico Dry Skin Treatment, by Medication USD Million (2018-2023)
  • Table 152. Mexico Dry Skin Treatment, by End User USD Million (2018-2023)
  • Table 153. Dry Skin Treatment: by Type(USD/Units)
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Dry Skin Treatment: by Type(USD Million)
  • Table 166. Dry Skin Treatment Moisturizer (Humectants, Emollients) , by Region USD Million (2025-2030)
  • Table 167. Dry Skin Treatment Medication (Topical Steroid, Antihistamines Agents, Immune modulator, Others) , by Region USD Million (2025-2030)
  • Table 168. Dry Skin Treatment: by Route of Administration(USD Million)
  • Table 169. Dry Skin Treatment Oral , by Region USD Million (2025-2030)
  • Table 170. Dry Skin Treatment Topical , by Region USD Million (2025-2030)
  • Table 171. Dry Skin Treatment: by Distribution Channel(USD Million)
  • Table 172. Dry Skin Treatment Hospital Pharmacy , by Region USD Million (2025-2030)
  • Table 173. Dry Skin Treatment Retail Pharmacy , by Region USD Million (2025-2030)
  • Table 174. Dry Skin Treatment Online Pharmacy , by Region USD Million (2025-2030)
  • Table 175. Dry Skin Treatment: by Medication(USD Million)
  • Table 176. Dry Skin Treatment OTC Products , by Region USD Million (2025-2030)
  • Table 177. Dry Skin Treatment Prescription Medications , by Region USD Million (2025-2030)
  • Table 178. Dry Skin Treatment: by End User(USD Million)
  • Table 179. Dry Skin Treatment Hospitals , by Region USD Million (2025-2030)
  • Table 180. Dry Skin Treatment Homecare , by Region USD Million (2025-2030)
  • Table 181. Dry Skin Treatment Others , by Region USD Million (2025-2030)
  • Table 182. South America Dry Skin Treatment, by Country USD Million (2025-2030)
  • Table 183. South America Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 184. South America Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 185. South America Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 186. South America Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 187. South America Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 188. Brazil Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 189. Brazil Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 190. Brazil Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 191. Brazil Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 192. Brazil Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 193. Argentina Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 194. Argentina Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 195. Argentina Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 196. Argentina Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 197. Argentina Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 198. Rest of South America Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 199. Rest of South America Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 200. Rest of South America Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 201. Rest of South America Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 202. Rest of South America Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 203. Asia Pacific Dry Skin Treatment, by Country USD Million (2025-2030)
  • Table 204. Asia Pacific Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 205. Asia Pacific Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 206. Asia Pacific Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 207. Asia Pacific Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 208. Asia Pacific Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 209. China Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 210. China Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 211. China Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 212. China Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 213. China Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 214. Japan Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 215. Japan Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 216. Japan Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 217. Japan Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 218. Japan Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 219. India Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 220. India Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 221. India Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 222. India Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 223. India Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 224. South Korea Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 225. South Korea Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 226. South Korea Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 227. South Korea Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 228. South Korea Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 229. Taiwan Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 230. Taiwan Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 231. Taiwan Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 232. Taiwan Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 233. Taiwan Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 234. Australia Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 235. Australia Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 236. Australia Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 237. Australia Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 238. Australia Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 239. Rest of Asia-Pacific Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 240. Rest of Asia-Pacific Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 241. Rest of Asia-Pacific Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 242. Rest of Asia-Pacific Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 243. Rest of Asia-Pacific Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 244. Europe Dry Skin Treatment, by Country USD Million (2025-2030)
  • Table 245. Europe Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 246. Europe Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 247. Europe Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 248. Europe Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 249. Europe Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 250. Germany Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 251. Germany Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 252. Germany Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 253. Germany Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 254. Germany Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 255. France Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 256. France Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 257. France Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 258. France Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 259. France Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 260. Italy Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 261. Italy Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 262. Italy Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 263. Italy Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 264. Italy Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 265. United Kingdom Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 266. United Kingdom Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 267. United Kingdom Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 268. United Kingdom Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 269. United Kingdom Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 270. Netherlands Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 271. Netherlands Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 272. Netherlands Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 273. Netherlands Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 274. Netherlands Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 275. Rest of Europe Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 276. Rest of Europe Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 277. Rest of Europe Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 278. Rest of Europe Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 279. Rest of Europe Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 280. MEA Dry Skin Treatment, by Country USD Million (2025-2030)
  • Table 281. MEA Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 282. MEA Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 283. MEA Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 284. MEA Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 285. MEA Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 286. Middle East Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 287. Middle East Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 288. Middle East Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 289. Middle East Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 290. Middle East Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 291. Africa Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 292. Africa Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 293. Africa Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 294. Africa Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 295. Africa Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 296. North America Dry Skin Treatment, by Country USD Million (2025-2030)
  • Table 297. North America Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 298. North America Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 299. North America Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 300. North America Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 301. North America Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 302. United States Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 303. United States Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 304. United States Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 305. United States Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 306. United States Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 307. Canada Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 308. Canada Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 309. Canada Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 310. Canada Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 311. Canada Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 312. Mexico Dry Skin Treatment, by Type USD Million (2025-2030)
  • Table 313. Mexico Dry Skin Treatment, by Route of Administration USD Million (2025-2030)
  • Table 314. Mexico Dry Skin Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 315. Mexico Dry Skin Treatment, by Medication USD Million (2025-2030)
  • Table 316. Mexico Dry Skin Treatment, by End User USD Million (2025-2030)
  • Table 317. Dry Skin Treatment: by Type(USD/Units)
  • Table 318. Research Programs/Design for This Report
  • Table 319. Key Data Information from Secondary Sources
  • Table 320. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dry Skin Treatment: by Type USD Million (2018-2023)
  • Figure 5. Global Dry Skin Treatment: by Route of Administration USD Million (2018-2023)
  • Figure 6. Global Dry Skin Treatment: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Dry Skin Treatment: by Medication USD Million (2018-2023)
  • Figure 8. Global Dry Skin Treatment: by End User USD Million (2018-2023)
  • Figure 9. South America Dry Skin Treatment Share (%), by Country
  • Figure 10. Asia Pacific Dry Skin Treatment Share (%), by Country
  • Figure 11. Europe Dry Skin Treatment Share (%), by Country
  • Figure 12. MEA Dry Skin Treatment Share (%), by Country
  • Figure 13. North America Dry Skin Treatment Share (%), by Country
  • Figure 14. Global Dry Skin Treatment: by Type USD/Units (2018-2023)
  • Figure 15. Global Dry Skin Treatment share by Players 2023 (%)
  • Figure 16. Global Dry Skin Treatment share by Players (Top 3) 2023(%)
  • Figure 17. Global Dry Skin Treatment share by Players (Top 5) 2023(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. L'Oreal SA (France) Revenue, Net Income and Gross profit
  • Figure 20. L'Oreal SA (France) Revenue: by Geography 2023
  • Figure 21. Galderma Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Galderma Laboratories (United States) Revenue: by Geography 2023
  • Figure 23. Sun Pharmaceutical Industries Ltd (India) Revenue, Net Income and Gross profit
  • Figure 24. Sun Pharmaceutical Industries Ltd (India) Revenue: by Geography 2023
  • Figure 25. Teva Pharmaceutical Industries Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 26. Teva Pharmaceutical Industries Ltd (Israel) Revenue: by Geography 2023
  • Figure 27. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 29. Pfizer Inc (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer Inc (United States) Revenue: by Geography 2023
  • Figure 31. MC2 Therapeutics (Denmark) Revenue, Net Income and Gross profit
  • Figure 32. MC2 Therapeutics (Denmark) Revenue: by Geography 2023
  • Figure 33. Croda International Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Croda International Plc (United Kingdom) Revenue: by Geography 2023
  • Figure 35. Unilever (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Unilever (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Johnson & Johnson Services, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 38. Johnson & Johnson Services, Inc (United States) Revenue: by Geography 2023
  • Figure 39. Perrigo Company plc (United States) Revenue, Net Income and Gross profit
  • Figure 40. Perrigo Company plc (United States) Revenue: by Geography 2023
  • Figure 41. Global Dry Skin Treatment: by Type USD Million (2025-2030)
  • Figure 42. Global Dry Skin Treatment: by Route of Administration USD Million (2025-2030)
  • Figure 43. Global Dry Skin Treatment: by Distribution Channel USD Million (2025-2030)
  • Figure 44. Global Dry Skin Treatment: by Medication USD Million (2025-2030)
  • Figure 45. Global Dry Skin Treatment: by End User USD Million (2025-2030)
  • Figure 46. South America Dry Skin Treatment Share (%), by Country
  • Figure 47. Asia Pacific Dry Skin Treatment Share (%), by Country
  • Figure 48. Europe Dry Skin Treatment Share (%), by Country
  • Figure 49. MEA Dry Skin Treatment Share (%), by Country
  • Figure 50. North America Dry Skin Treatment Share (%), by Country
  • Figure 51. Global Dry Skin Treatment: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • L'Oreal SA (France)
  • Galderma Laboratories (United States)
  • Sun Pharmaceutical Industries Ltd (India)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Bayer AG (Germany)
  • Pfizer Inc (United States)
  • MC2 Therapeutics (Denmark)
  • Croda International Plc (United Kingdom)
  • Unilever (United Kingdom)
  • Johnson & Johnson Services, Inc (United States)
  • Perrigo Company plc (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 225 Pages 65 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dry Skin Treatment Market Quantitative research analysis
Global Dry Skin Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as L'Oreal SA (France), Galderma Laboratories (United States), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Bayer AG (Germany), Pfizer Inc (United States), MC2 Therapeutics (Denmark), Croda International Plc (United Kingdom), Unilever (United Kingdom), Johnson & Johnson Services, Inc (United States) and Perrigo Company plc (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Dry Skin Treatment Market during projected period 2023-2030.
The Dry Skin Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dry Skin Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Sangers Sequencing Service Comprehensive Study by Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other), Laboratory (Web Lab, Dry Lab), Servic...
$ 3750
Surgical Slush Units Comprehensive Study by Type (Basin-based, Container-based), Application (Ambulatory Surgery Centers, Hospitals, Trauma Centers, Others), Procedure (Transplant Surgical Procedures...
$ 3650
Veterinary Stereotactic Radiosurgery Comprehensive Study by Type (Gamma Knife, Linear Accelerator, Particle Beam Radiation therapy, Cyber Knife), Application (Veterinary Hospitals, Veterinary Clinics...
$ 3650
Prescription Delivery Services Comprehensive Study by Type (Therapeutic Drugs, Diabetes Drugs, Cholesterol Disorders Drugs, Wellness Supplements, OTC Drugs, Diagnostic Kits, Others), Delivery Type (P...
$ 3450
Peri implantitis Comprehensive Study by Type (Non-surgical treatment, Surgical treatment), Therapy Class (Class-1, Classs-2, Class-3, Class-4), Severity (Early(PD>=4mm), Moderate(PD>=6mm), Advanced(P...
$ 3350
Breast Recurrence Score Test Comprehensive Study by Type (First-Generation Test, Second Generation Test), Indication (Stage I Invasive Breast Cancer, Stage II Invasive Breast Cancer, Estrogen Recepto...
$ 3650